{"organizations": [], "uuid": "cc003c9a3e40d343250f310c76018dfa0e54b962", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-itus-and-serametrix-announce-resul/brief-itus-and-serametrix-announce-results-of-a-blinded-prostate-cancer-study-idUSFWN1R90A7", "country": "US", "domain_rank": 408, "title": "BRIEF-Itus And Serametrix Announce Results Of A Blinded Prostate Cancer Study", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-27T14:19:00.000+03:00", "replies_count": 0, "uuid": "cc003c9a3e40d343250f310c76018dfa0e54b962"}, "author": "", "url": "https://www.reuters.com/article/brief-itus-and-serametrix-announce-resul/brief-itus-and-serametrix-announce-results-of-a-blinded-prostate-cancer-study-idUSFWN1R90A7", "ord_in_thread": 0, "title": "BRIEF-Itus And Serametrix Announce Results Of A Blinded Prostate Cancer Study", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 23 AM / Updated 7 minutes ago BRIEF-Itus And Serametrix Announce Results Of A Blinded Prostate Cancer Study Reuters Staff March 27 (Reuters) - Itus Corp: * ITUS AND SERAMETRIX ANNOUNCE RESULTS OF A BLINDED PROSTATE CANCER STUDY * ITUS- ALONG WITH SERAMETRIX, CO EVALUATING WHETHER CCHEK MAY BE UTILIZED TO DISTINGUISH BETWEEN RESPONDERS AND NON-RESPONDERS TO IMMUNE-THERAPIES * ITUS CORP - ITUS CORRECTLY IDENTIFIED 33 OF 36 PROSTATE CANCER SAMPLES AND 34 OF 37 HEALTHY DONOR SAMPLES Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-27T14:19:00.000+03:00", "crawled": "2018-03-27T14:33:18.008+03:00", "highlightTitle": ""}